Fidelity Investments’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Fidelity Investments’s Portfolio TRIV Stock Details TRIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-2,550,000	Closed	-$17M	–	2825
2015 Q4	$17M	Hold	2,550,000	–	–	﹤0.01%	1759
2015 Q3	$12.8M	Hold	2,550,000	–	–	﹤0.01%	1845
2015 Q2	$13.6M	Buy	2,550,000 +498,848	+24%	+$3.54M	﹤0.01%	1898
2015 Q1	$21.5M	Buy	2,051,152 +448,752	+28%	+$4.62M	﹤0.01%	1704
2014 Q4	$20.1M	Buy	1,602,400 +122,400	+8%	+$1.67M	﹤0.01%	1722
2014 Q3	$21.4M	Buy	1,480,000 +15,389	+1%	+$223K	﹤0.01%	1707
2014 Q2	$22.8M	Buy	+1,464,611	New	+$22.2M	﹤0.01%	1738

Fidelity Investments's TRIV Position: Q1 2016 in Review

Fidelity Investments sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2016, closing a stake of 2,550,000 shares — an estimated $17M sold.

Fidelity Investments first reported a position in TRIV in Q2 2014 and held it in 7 quarters. The position peaked at $22.8M in Q2 2014. 0 funds tracked by Wall St. Rank hold TRIV as of Q1 2016.

Fidelity Investments reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2016 after selling out during the quarter.
Fidelity Investments sold 2,550,000 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2016, an estimated $17M.
Fidelity Investments first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 7 quarters.
Fidelity Investments's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $22.8M in Q2 2014.
0 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2016.

Based on Fidelity Investments's 13F filing for Q1 2016, filed 16 May 2016.